Back to search

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.

Data up to Jan 2025

Published2003
Citations64
References18
Clinical Trials (1)

Total Citations Per Year

Abstract

References (18)

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

1996 • 1,584 citations

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1997 • 1,235 citations

Classification of prostatic carcinomas.

1966 • 1,101 citations

Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends

2001 • 758 citations

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 • 728 citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 • 712 citations

The Present Status of Radical Prostatectomy for Stages A and B Prostatic Cancer

1975 • 445 citations

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers

2000 • 435 citations

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

2000 • 407 citations

Cancer Tumor antigens

1997 • 289 citations

LAGE-1, a new gene with tumor specificity

1998 • 268 citations

A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames

1998 • 208 citations

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen ny-eso-1 but not mage-a1 or ct7

2001 • 197 citations

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.

2001 • 123 citations

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele

2000 • 108 citations

CHEMOTHERAPY FOR HORMONE REFRACTORY PROSTATE CANCER

1999 • 40 citations

Novel Cloning Method for Recombinant Adenovirus Construction in Escherichia coli

1999 • 24 citations

HISTOPATHOLOGICAL COMPARISON OF PROSTATIC ADENOCARCINOMA IN JAPAN AND THE UNITED STATES

1993 • 11 citations

Cited By (0)

No citing papers found in database

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. (2003) – PubMed | Metascience Observatory Explorer